Applied Therapeutics Inc. (APLT)
NASDAQ: APLT
· Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM
0.50
4.79%
After-hours: Aug 21, 2025, 07:46 PM EDT
Applied Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -21.82M | 44.01M | -68.59M | 2.9M | -83.94M | -37.68M | -42.37M | -29.58M | -10.14M | -14.43M | -19.1M | -25.86M | -23.12M | -27.16M | -28.42M | -25.83M | -24.18M |
Depreciation & Amortization | 104K | 80K | 325K | 122K | 119K | 6K | 118K | 116K | 114K | 114K | 112K | 109K | 108K | 107K | 104K | 104K | 100K |
Stock-Based Compensation | 1.49M | 7.11M | 2.09M | 1.89M | 2.38M | 1.63M | 1.84M | 1.84M | 2.06M | 2M | 2.86M | 2.23M | 2.08M | 2.85M | 2.65M | 2.7M | 2.98M |
Other Working Capital | n/a | 3.89M | 5.8M | -5.23M | -1.66M | 5.97M | -3.17M | -1.22M | -223K | 2.45M | -2.17M | -3.92M | -270K | -2.92M | 4.25M | -1.63M | -4.84M |
Other Non-Cash Items | n/a | -76.15M | 36.89M | -20.97M | 65.76M | 59.14M | -121K | -884K | 180K | -3.59M | 635K | 6.27M | 335K | -105K | -101K | -101K | -97K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -41.8M | 27.66M | 14.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -990K | 990K |
Change in Working Capital | n/a | 5.49M | 5.95M | -4.81M | -1.14M | 1.7M | -1.85M | -2.09M | 798K | 11K | -3.89M | -1.15M | -3.81M | -2.63M | 10.11M | -1.79M | -2.01M |
Operating Cash Flow | -28.64M | -19.47M | -23.33M | -22.59M | -18.91M | -17M | -14.73M | -16.45M | -6.99M | -15.89M | -19.39M | -18.4M | -24.41M | -26.94M | -15.66M | -25.91M | -22.21M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -27.31M | -21.92M | -8.99M | -5.99M | -12.47M | -14.57M | -6.54M | -88.01M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.87M | 20.4M | 26.95M | 14.52M | 15.52M | 24.28M | 23.09M | 23.32M | 63.34M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.91M | 5.02M | 5.53M | 9.53M | 11.81M | 8.52M | 16.78M | -24.67M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.87M | -6.91M | 5.02M | 5.53M | 9.53M | 11.81M | 8.52M | 16.78M | -24.67M |
Debt Repayment | n/a | n/a | n/a | n/a | -311K | -465K | -465K | -306K | -622K | -933K | -932K | -619K | -789K | -1.18M | -1.18M | -1.28M | -1.07M |
Common Stock Repurchased | n/a | n/a | 1.69M | -1.69M | n/a | n/a | n/a | n/a | n/a | n/a | -39K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 310K | 9.06M | 3K | 10.32M | 1.57M | n/a | n/a | 49K | 3.1M | n/a | -1K | 104K | 4.78M | 136K |
Financial Cash Flow | n/a | n/a | n/a | -1.69M | 115.5M | 29.45M | 16.57M | 29.15M | -622K | -933K | -971K | 30.39M | -789K | -1.18M | -1.08M | 3.5M | 73.49M |
Net Cash Flow | -28.64M | -19.47M | -23.33M | -24.29M | 109.03M | 12.44M | 1.84M | 12.7M | 6.26M | -23.73M | -15.34M | 17.51M | -15.67M | -16.32M | -8.23M | -5.63M | 26.6M |
Free Cash Flow | -28.64M | -19.47M | -23.33M | -22.59M | -18.91M | -17M | -14.73M | -16.45M | -6.99M | -15.89M | -19.39M | -18.4M | -24.41M | -26.94M | -15.66M | -25.91M | -22.21M |